
Last updated: 3 months ago
Evogene Ltd. 6-K Report: Shareholder Meeting Approves Key Proposal
Explore Evogene Ltd.'s February 2025 6-K report detailing shareholder approval of a critical proposal, enhancing transparency and governance.
Explore Evogene Ltd.'s February 2025 6-K report detailing shareholder approval of a critical proposal, enhancing transparency and governance.
Evogene Ltd. files Form 6-K on Jan 15, 2025, detailing Mr. Eyal Ronen's departure and commitment to strategic continuity.